PRESS RELEASE published on 10/24/2024 at 19:30, 5 months 25 days ago Inside Information / Other news releases ABIONYX Pharma's RACERS study on CER-001 shows positive impact on cognitive impairment in brain-fog patients, presenting new clinical results at ASN 2024 Annual Meeting. Potential treatment for neuroinflammation ABIONYX Pharma CER-001 Brain-fog Neuroinflammation RACERS Study
PRESS RELEASE published on 10/24/2024 at 19:30, 5 months 25 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma présente les résultats cliniques de l'étude RACERS sur le brouillard cérébral et l'efficacité de CER-001 au congrès annuel 2024 de l'ASN. Nouvelles données sur la neuro-inflammation et les troubles cognitifs ASN ABIONYX Pharma CER-001 Brain-fog Étude RACERS
BRIEF published on 10/21/2024 at 20:05, 5 months 28 days ago ABIONYX Pharma receives positive EMA opinion for CER-001 ABIONYX Pharma CER-001 EMA AMM LCAT Deficiency
BRIEF published on 10/21/2024 at 20:05, 5 months 28 days ago ABIONYX Pharma reçoit un avis favorable de l'EMA pour le CER-001 ABIONYX Pharma CER-001 EMA Déficience LCAT AMM
PRESS RELEASE published on 10/21/2024 at 20:00, 5 months 28 days ago Inside Information / Other news releases ABIONYX Pharma receives positive feedback from EMA for CER-001 in LCAT Deficiency, allowing submission of data from 2 prospective process validation batches for MAA manufacturing ABIONYX Pharma CER-001 EMA LCAT Deficiency Process Validation Batches
PRESS RELEASE published on 10/21/2024 at 20:00, 5 months 28 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma reçoit un avis positif de l'EMA pour le CER-001 dans la Déficience en LCAT. L'EMA admissible à la soumission de deux lots prospectifs de validation du procédé de fabrication ABIONYX Pharma CER-001 EMA LCAT Validation Du Procédé
BRIEF published on 08/22/2024 at 18:05, 7 months 27 days ago ABIONYX Pharma: Review of the first half of 2024 Biotechnology Fundraising Treasury Turnover ABIONYX Pharma
BRIEF published on 08/22/2024 at 18:05, 7 months 27 days ago ABIONYX Pharma : Bilan du 1er semestre 2024 Chiffre D'affaires Biotechnologie Trésorerie Levée De Fonds ABIONYX Pharma
PRESS RELEASE published on 08/22/2024 at 18:00, 7 months 27 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma publie sa position de trésorerie du 1er semestre 2024 avec un chiffre d’affaires consolidé de 2,4 M€. Levée de fonds de 3,4 M€ pour renforcer la trésorerie Chiffre D'affaires Biotechnologie Trésorerie Levée De Fonds ABIONYX Pharma
PRESS RELEASE published on 08/22/2024 at 18:00, 7 months 27 days ago Inside Information / Other news releases ABIONYX Pharma reports €2.4m sales and €5.3m cash position for H1 2024, focused on innovative therapies. Raised €3.4m for sepsis program in the US Sales Cash Position Innovative Therapies ABIONYX Pharma Sepsis
Published on 04/18/2025 at 01:20, 21 hours 46 minutes ago Aston Bay Files Technical Report for Storm Copper Project Initial Mineral Resource Estimate
Published on 04/18/2025 at 00:00, 23 hours 6 minutes ago Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology
Published on 04/17/2025 at 23:15, 23 hours 51 minutes ago EON Resources Inc. Announces Fiscal Year 2024 Earnings Call on April 23, 2025
Published on 04/18/2025 at 18:00, 5 hours 6 minutes ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.25.
Published on 04/18/2025 at 17:54, 5 hours 11 minutes ago VALBIOTIS SA: Compte-rendu de l’Assemblée générale mixte du 18 avril 2025
Published on 04/18/2025 at 17:52, 5 hours 13 minutes ago Market entry in France – Cicor acquires significant business activities of Éolane
Published on 04/18/2025 at 17:45, 5 hours 21 minutes ago Linedata Services: Déclaration des transactions sur actions propres opération du 16 avril 2025
Published on 04/18/2025 at 17:45, 5 hours 20 minutes ago Saint-Gobain once again featured on CDP’s “Climate A List”
Published on 04/18/2025 at 17:45, 5 hours 20 minutes ago Saint-Gobain figure une nouvelle fois sur la « Climate A List » établie par le CDP
Published on 04/18/2025 at 11:16, 11 hours 49 minutes ago Déclaration hebdomadaire d'opérations effectuées du 14 au 17 avril 2025
Published on 04/18/2025 at 11:16, 11 hours 49 minutes ago Disclosure of transactions in own shares from April 14 to April 17, 2025
Published on 04/18/2025 at 07:00, 16 hours 6 minutes ago Uitnodiging voor de Jaarvergadering en Buitengewone Algemene Vergadering van aandeelhouders
